Matarin Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $2.95M | Buy |
+27,513
| New | +$2.95M | 0.72% | 57 |
|
|
2020
Q2 | – | Sell |
-50,372
| Closed | -$3.84M | – | 191 |
|
|
2020
Q1 | $3.84M | Buy |
50,372
+4,294
| +9% | +$327K | 0.6% | 79 |
|
|
2019
Q4 | $4.08M | Buy |
46,078
+3,075
| +7% | +$272K | 0.39% | 121 |
|
|
2019
Q3 | $3.26M | Buy |
43,003
+935
| +2% | +$70.8K | 0.25% | 146 |
|
|
2019
Q2 | $3.06M | Buy |
+42,068
| New | +$3.06M | 0.22% | 154 |
|
|
2019
Q1 | – | Sell |
-37,249
| Closed | -$3.43M | – | 263 |
|
|
2018
Q4 | $3.43M | Sell |
37,249
-9,714
| -21% | -$896K | 0.28% | 132 |
|
|
2018
Q3 | $4.44M | Buy |
46,963
+10,390
| +28% | +$983K | 0.29% | 117 |
|
|
2018
Q2 | $3.39M | Sell |
36,573
-7,230
| -17% | -$670K | 0.25% | 135 |
|
|
2018
Q1 | $4.15M | Sell |
43,803
-8,633
| -16% | -$817K | 0.31% | 118 |
|
|
2017
Q4 | $5.07M | Buy |
52,436
+12,394
| +31% | +$1.2M | 0.39% | 97 |
|
|
2017
Q3 | $3.56M | Sell |
40,042
-22,659
| -36% | -$2.01M | 0.3% | 134 |
|
|
2017
Q2 | $4.55M | Buy |
+62,701
| New | +$4.55M | 0.42% | 102 |
|
|
2016
Q4 | – | Sell |
-88,937
| Closed | -$5.61M | – | 229 |
|
|
2016
Q3 | $5.61M | Buy |
+88,937
| New | +$5.61M | 0.62% | 69 |
|
|
2015
Q4 | – | Sell |
-10,755
| Closed | -$585K | – | 221 |
|
|
2015
Q3 | $585K | Buy |
+10,755
| New | +$585K | 0.12% | 172 |
|
|
2015
Q2 | – | Sell |
-24,572
| Closed | -$1.44M | – | 193 |
|
|
2015
Q1 | $1.44M | Buy |
24,572
+8,039
| +49% | +$471K | 0.44% | 112 |
|
|
2014
Q4 | $1.08M | Buy |
+16,533
| New | +$1.08M | 0.47% | 106 |
|